Theraclion specializes in developping, manufacturing and marketing echotherapy equipment associating therapy with focused ultrasound (HIFU) and monitoring by ultrasound. The company provides Echopulse, a device for non-invasive and outpatient treatment of mammary fibroadenoma and thyroid nodules.Net sales break down by activity as follows: - sale of consumables (52.8%); - sale of equipment (28.8%); - provision of after-sales services (18.4%). The vast majority of net sales are earned abroad.

Employees

Sector

Advanced Medical Equipment & Technology

More about the company

Quotes

Date	Price	Change	Volume
26-07-28	€0.5950	+0.34%	26
26-07-27	€0.5930	0.00%	57,248
26-07-24	€0.5930	-10.15%	228,325
26-07-23	€0.6600	-0.90%	4,394
26-07-22	€0.6660	+1.68%	53,336

Real-time Euronext Paris

More quotes

Income Statement and Estimates

More financial data

Annual profits - Rate of surprise

Company calendar

Real-time Euronext Paris Other stock markets 03:00:14 2026-07-28 EDT			5-day change	1st Jan Change
0.5950 ^EUR	+0.34%		-9.16%	-1.16%

07-09	Theraclion Announces Board Changes	CI
07-09	Theraclion Appoints New Chairman	MT

Market Cap	43.35M 49.32M 40.36M 37.06M 69.59M 4.73B 70.51M 480M 187M 2.34B 185M 181M 8.07B	P/E 2024	-2.66x	P/E 2025	-6.33x
Enterprise Value	51.21M 58.25M 47.67M 43.77M 82.2M 5.59B 83.28M 567M 221M 2.76B 219M 214M 9.53B	EV / Sales 2024	22.5x	EV / Sales 2025	55.4x
Free-Float	54.37%	Yield 2024 *	-	Yield 2025	-

07-09	Theraclion Announces Board Changes	CI
07-09	Theraclion Appoints New Chairman	MT
06-19	Claude Lenoir appointed interim chairman of Theraclion
06-19	Theraclion Chairman Steps Down; Interim Successor Named	MT
06-18	Theraclion Announces Board Changes	CI
06-08	Theraclion Secures AMA CPT Editorial Panel Approval For New Category III CPT Code For Sonovein	CI
06-05	Theraclion deploys first Sonovein system in China
06-05	Theraclion JV Deploys Sonovein System at Chinese Hospital	MT
06-04	Theraclion Announces First Clinical Deployment Of Sonovein In Hainan, China	CI
06-04	Theraclion Deploys Sonovein System At Boao Super Hospital in Hainan Province	CI
06-01	Theraclion Presents Promising Preliminary Results From Sonovein SpeedPulse At First International HIFU Congress	CI
05-11	Bouygues, Euronext, Vallourec... stocks to watch today in Paris
05-11	Theraclion raises nearly 6 million euros via units with warrants

07-23	Theraclion Initiates Its Commercial Momentum in the First Half of 2026	BU
07-15	Theraclion: First Half 2026 Report on the Liquidity Contract With CRÉDIT INDUSTRIEL ET COMMERCIAL	BU
07-09	Theraclion Strengthens Its Governance by Appointing Vincent Gardès as Chairman of Its Board of Directors	BU
06-18	Theraclion Announces the Evolution of Its Board of Directors	BU
06-08	Theraclion Secures Key U.S. Reimbursement Milestone for Sonovein® With AMA CPT Editorial Panel Approval of a New Category III CPT Code	BU

Theraclion Stock

Stocks

ALTHE

FR0010120402

Advanced Medical Equipment & Technology

Valuation: Theraclion

Chart: Theraclion

Latest news : Theraclion

Press Releases: Theraclion

News in other languages: Theraclion

Quotes and Performance

Course Extremes

Managers and Directors: Theraclion

Latest insider transactions

Other Advanced Medical Equipment & Technology

Financials

Company Profile

Quotes

Income Statement and Estimates

Annual profits - Rate of surprise

07-23	THERACLION AMORCE SA DYNAMIQUE COMMERCIALE AU PREMIER SEMESTRE 2026
07-15	Theraclion: BILAN DU PREMIER SEMESTRE 2026 DU CONTRAT DE LIQUIDITÉ CONTRACTÉ AVEC LE CRÉDIT INDUSTRIEL ET COMMERCIAL
07-09	Vincent Gardès prend la présidence du conseil d'administration de Theraclion
07-09	THERACLION RENFORCE SA GOUVERNANCE EN NOMMANT VINCENT GARDÈS À LA PRÉSIDENCE DE SON CONSEIL D'ADMINISTRATION
06-19	Bourse : Crédit Agricole veut jouer un rôle en Italie, 2CRSi va communiquer

1 day	+0.34%
1 week	-9.16%
Current month	-5.25%
1 month	-6.30%
3 months	+16.21%
6 months	-25.25%
Current year	-1.16%

1 week	0.56	0.67
1 month	0.56	0.69
Current year	0.4	0.93
1 year	0.4	1.25
3 years	0.14	1.25
5 years	0.14	2.22
10 years	0.14	7.46

Manager	Title	Age	Since
Martin Deterre CEO	Chief Executive Officer	-	2023-05-23
Julie Veisseire DFI	Director of Finance/CFO	-	-
Alexandra Rocher COO	Chief Operating Officer	-	-

Director	Title	Age	Since
Renaud Saleur BRD	Director/Board Member	-	2018-01-31
Ari Kellen BRD	Director/Board Member	-	2019-02-12
Shawn Langer BRD	Director/Board Member	-	2019-02-12

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
THERACLION	+0.34%	-9.16%	-10.93%	+2.59%	49.32M
THERMO FISHER SCIENTIFIC, INC.	-1.54%	+6.33%	+16.98%	-0.09%	208B
DANAHER CORPORATION	+2.61%	-2.29%	-4.37%	-23.02%	138B
INTUITIVE SURGICAL, INC.	+5.73%	+1.04%	-28.04%	+10.28%	126B
BOSTON SCIENTIFIC CORPORATION	+2.85%	+3.98%	-57.12%	-13.54%	67.64B
EDWARDS LIFESCIENCES CORPORATION	+0.50%	-2.31%	+3.80%	+0.45%	47.81B
SIEMENS HEALTHINEERS AG	-0.80%	+0.59%	-25.87%	-33.53%	45.03B
AGILENT TECHNOLOGIES, INC.	-0.49%	+5.86%	+14.74%	+8.87%	38.94B
WATERS CORPORATION	-0.93%	+3.82%	+22.53%	+30.15%	36.45B
ILLUMINA, INC.	-2.38%	+2.59%	+73.35%	-0.12%	28.67B
Average	+0.60%	+0.54%	+0.51%	-1.80%	73.67B
Weighted average by Cap.	+1.12%	+1.46%	-2.66%	-3.89%

	2024	2025
Net sales	830K 944K 773K 710K 1.33M 90.57M 1.35M 9.19M 3.59M 44.72M 3.55M 3.47M 155M	652K 742K 607K 557K 1.05M 71.13M 1.06M 7.21M 2.82M 35.12M 2.78M 2.72M 121M
Net income	-5.76M -6.55M -5.36M -4.92M -9.24M -628M -9.36M -63.7M -24.88M -310M -24.58M -24.05M -1.07B	-5.69M -6.47M -5.3M -4.86M -9.13M -621M -9.25M -62.96M -24.59M -306M -24.3M -23.77M -1.06B
Net Debt	3.41M 3.88M 3.17M 2.92M 5.48M 372M 5.55M 37.74M 14.74M 184M 14.56M 14.25M 635M	7.85M 8.93M 7.31M 6.71M 12.6M 857M 12.77M 86.88M 33.93M 423M 33.53M 32.81M 1.46B